The concern of generic rivalry has repeatedly loomed above copyright’s famous drug, Sildenafil, sparking questions about the future of similar drug holdings. While first times saw substantial profits, the intellectual property expiration has allowed the door for less expensive copies, possibly diminishing earnings and posing a real risk for inves